Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.

Penaranda C, Kuswanto W, Hofmann J, Kenefeck R, Narendran P, Walker LS, Bluestone JA, Abbas AK, Dooms H.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12668-73. doi: 10.1073/pnas.1203692109. Epub 2012 Jun 25.

2.

Interleukin-7: Fuel for the autoimmune attack.

Dooms H.

J Autoimmun. 2013 Sep;45:40-8. doi: 10.1016/j.jaut.2013.06.007. Epub 2013 Jul 4. Review.

PMID:
23831438
3.

Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.

Racapé M, Vanhove B, Soulillou JP, Brouard S.

Arch Immunol Ther Exp (Warsz). 2009 Jul-Aug;57(4):253-61. doi: 10.1007/s00005-009-0036-7. Epub 2009 Jul 8. Review.

PMID:
19585222
4.

Interleukin-7 and type 1 diabetes.

Monti P, Bonifacio E.

Curr Diab Rep. 2014;14(9):518. doi: 10.1007/s11892-014-0518-9. Review.

PMID:
24996523
5.

Targeting memory T cells in type 1 diabetes.

Ehlers MR, Rigby MR.

Curr Diab Rep. 2015 Nov;15(11):84. doi: 10.1007/s11892-015-0659-5. Review.

PMID:
26370695
6.

Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Staerz UD, Qi Y.

J Clin Immunol. 1999 Jul;19(4):195-202. Review.

PMID:
10471973
7.

Regulatory T cells and type 1 diabetes.

Bisikirska BC, Herold KC.

Curr Diab Rep. 2005 Apr;5(2):104-9. Review.

PMID:
15794912
8.

Interleukin-7 and Immunosenescence.

Nguyen V, Mendelsohn A, Larrick JW.

J Immunol Res. 2017;2017:4807853. doi: 10.1155/2017/4807853. Epub 2017 Apr 6. Review.

9.

Individual T cells hold unexpected clues to the nature of anergy and memory.

Wells AD, Turka LA.

Immunol Res. 1998;17(1-2):261-8. Review.

PMID:
9479587

Supplemental Content

Support Center